Search Results

Keywords: tilray

Cannabis firm Tilray reports $341 million net loss in last stand-alone quarter

Tilray’s recreational and medical cannabis revenue plunged in the final quarter before its merger with Aphria went into effect May 3, and the company recorded a net loss of nearly $350 million. Tilray’s red ink rose in part due to a large litigation settlement, according to the British Columbia-based company’s first-quarter financial disclosure. Before merging […]

Read More

Tilray, Aphria complete blockbuster marijuana merger

Once-rival cannabis producers Tilray and Aphria completed their megamerger, the new company announced Monday, forming one of the biggest diversified marijuana, hemp and beer companies in the world. The new company will operate under the Tilray corporate name, with shares trading on the Nasdaq under the ticker symbol TLRY. The merger talks took more than […]

Read More

Cannabis firm Tilray reduces minimum quorum after delayed investor meeting

British Columbia-based Tilray amended its bylaws to reduce the required quorum for shareholder meetings, the cannabis producer said in a news release. The move comes one day after the company postponed a special meeting regarding its pending merger with Aphria, effectively giving stockholders additional time to vote on the business combination. This means the required quorum […]

Read More

Cannabis producer Tilray postpones shareholder vote on Aphria merger

Canadian cannabis producer Tilray postponed a special shareholder meeting to vote on its proposed megamerger with Aphria. The meeting, which was originally scheduled for Friday, will now be held two weeks later, on April 30. Tilray offered little explanation for the last-minute postponement in a news release issued Thursday, except to say the delay will […]

Read More

Aphria, Tilray to host April shareholder meetings about planned merger

Aphria and Tilray will host special shareholder meetings next month on the proposed merger between the cannabis producers, the companies said. The meetings will be held via live audio webcast for Aphria and Tilray shareholders on April 14 and April 16, respectively. According to a news release, Aphria shareholders must vote their proxies before 4 […]

Read More

Aphria-Tilray cannabis merger talks overcame pandemic pause, rival bidder and other hurdles, proxy reveals

On-again, off-again merger talks between rival cannabis producers Tilray and Aphria had their genesis in October 2019 when an unidentified investment bank active in the marijuana space pitched a meeting between the company’s respective CEOs, according to a proxy statement filed with regulators. From there, the blockbuster merger took more than a year to finalize: […]

Read More

Canadian marijuana producer Tilray reports $271 million loss for year

Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million loss in 2019, according to the full-year and fourth-quarter results released Wednesday. Tilray, which is on the verge of being merged with Canadian peer Aphria, lost only $3 million in its fourth quarter […]

Read More

Tilray adds dronabinol to German product portfolio

Canadian cannabis producer Tilray is offering dronabinol in the German medical cannabis market, according to a notice in the German trade publication Apotheke AdHoc. Tilray’s dronabinol is plant-derived – like most, if not all, of the dronabinol available in Germany. According to the notice, Tilray sources the dronabinol from manufacturer Echo Pharmaceuticals in the Netherlands. […]

Read More

More Tilray cannabis product recalls in Germany, report says

British Columbia, Canada-based Tilray is recalling new batches of medical cannabis extracts in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported. It is the second recall of Tilray products in Germany this summer. According to DAZ, Tilray recalled a total of six batches of the same product: THC10:CBD10. The extract is a […]

Read More

Tilray revenue hit by lower recreational, medical cannabis sales

Nanaimo, British Columbia-based Tilray halved its net loss to $81.7 million for the second quarter ended June 30, a substantial improvement over the previous quarter’s $184.1 million deficit. However, the cannabis producer reported lower sequential revenue in most of its important categories. Tilray reports in U.S. dollars. Overall revenue for the period was $50.4 million, […]

Read More